The immunologic constant of rejection

Ena Wang, Andrea Worschech, Francesco M. Marincola

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

The complexity underlying a pathologic process does not necessarily require a complex explanation. The biology determining allograft or cancer rejection, autoimmunity or tissue damage during pathogen infections is complex; however, common patterns are emerging that lead to a common final outcome. For instance, tissue destruction occurs with resolution of the pathogenic process (cancer, infection) or tissue damage and organ failure (autoimmunity, allograft rejection). Observations in humans based on transcriptional profiling converge into what we call an 'immunologic constant of rejection' that characterizes such occurrences. This constant includes the coordinate activation of interferon-stimulated genes (ISGs) and immune effector functions (IEFs). Understanding this final effector pathway may suggest novel strategies for the induction or inhibition of tissue-specific destruction with therapeutic intent in cancer and other immune pathologies.

Original languageEnglish
Pages (from-to)256-262
Number of pages7
JournalTrends in Immunology
Volume29
Issue number6
DOIs
Publication statusPublished - Jun 2008
Externally publishedYes

Fingerprint

Autoimmunity
Allografts
Neoplasms
Pathologic Processes
Infection
Interferons
Pathology
Genes
Therapeutics

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

The immunologic constant of rejection. / Wang, Ena; Worschech, Andrea; Marincola, Francesco M.

In: Trends in Immunology, Vol. 29, No. 6, 06.2008, p. 256-262.

Research output: Contribution to journalArticle

Wang, E, Worschech, A & Marincola, FM 2008, 'The immunologic constant of rejection', Trends in Immunology, vol. 29, no. 6, pp. 256-262. https://doi.org/10.1016/j.it.2008.03.002
Wang, Ena ; Worschech, Andrea ; Marincola, Francesco M. / The immunologic constant of rejection. In: Trends in Immunology. 2008 ; Vol. 29, No. 6. pp. 256-262.
@article{e7f0287554ff4a9f83b57b4908d715b7,
title = "The immunologic constant of rejection",
abstract = "The complexity underlying a pathologic process does not necessarily require a complex explanation. The biology determining allograft or cancer rejection, autoimmunity or tissue damage during pathogen infections is complex; however, common patterns are emerging that lead to a common final outcome. For instance, tissue destruction occurs with resolution of the pathogenic process (cancer, infection) or tissue damage and organ failure (autoimmunity, allograft rejection). Observations in humans based on transcriptional profiling converge into what we call an 'immunologic constant of rejection' that characterizes such occurrences. This constant includes the coordinate activation of interferon-stimulated genes (ISGs) and immune effector functions (IEFs). Understanding this final effector pathway may suggest novel strategies for the induction or inhibition of tissue-specific destruction with therapeutic intent in cancer and other immune pathologies.",
author = "Ena Wang and Andrea Worschech and Marincola, {Francesco M.}",
year = "2008",
month = "6",
doi = "10.1016/j.it.2008.03.002",
language = "English",
volume = "29",
pages = "256--262",
journal = "Trends in Immunology",
issn = "1471-4906",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - The immunologic constant of rejection

AU - Wang, Ena

AU - Worschech, Andrea

AU - Marincola, Francesco M.

PY - 2008/6

Y1 - 2008/6

N2 - The complexity underlying a pathologic process does not necessarily require a complex explanation. The biology determining allograft or cancer rejection, autoimmunity or tissue damage during pathogen infections is complex; however, common patterns are emerging that lead to a common final outcome. For instance, tissue destruction occurs with resolution of the pathogenic process (cancer, infection) or tissue damage and organ failure (autoimmunity, allograft rejection). Observations in humans based on transcriptional profiling converge into what we call an 'immunologic constant of rejection' that characterizes such occurrences. This constant includes the coordinate activation of interferon-stimulated genes (ISGs) and immune effector functions (IEFs). Understanding this final effector pathway may suggest novel strategies for the induction or inhibition of tissue-specific destruction with therapeutic intent in cancer and other immune pathologies.

AB - The complexity underlying a pathologic process does not necessarily require a complex explanation. The biology determining allograft or cancer rejection, autoimmunity or tissue damage during pathogen infections is complex; however, common patterns are emerging that lead to a common final outcome. For instance, tissue destruction occurs with resolution of the pathogenic process (cancer, infection) or tissue damage and organ failure (autoimmunity, allograft rejection). Observations in humans based on transcriptional profiling converge into what we call an 'immunologic constant of rejection' that characterizes such occurrences. This constant includes the coordinate activation of interferon-stimulated genes (ISGs) and immune effector functions (IEFs). Understanding this final effector pathway may suggest novel strategies for the induction or inhibition of tissue-specific destruction with therapeutic intent in cancer and other immune pathologies.

UR - http://www.scopus.com/inward/record.url?scp=44549086338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44549086338&partnerID=8YFLogxK

U2 - 10.1016/j.it.2008.03.002

DO - 10.1016/j.it.2008.03.002

M3 - Article

C2 - 18457994

AN - SCOPUS:44549086338

VL - 29

SP - 256

EP - 262

JO - Trends in Immunology

JF - Trends in Immunology

SN - 1471-4906

IS - 6

ER -